المؤلفون: Casali, P G, Bielack, S, Abecassis, N, Aro, H T, Bauer, S, Biagini, R, Bonvalot, S, Boukovinas, I, Bovee, J V M G, Brennan, B, Brodowicz, T, Broto, J M, Brugières, L, Buonadonna, A, De Álava, E, Dei Tos, A P, Del Muro, X G, Dileo, P, Dhooge, C, Eriksson, M, Fagioli, F, Fedenko, A, Ferraresi, V, Ferrari, A, Ferrari, S, Frezza, A M, Gaspar, N, Gasperoni, S, Gelderblom, H, Gil, T, Grignani, G, Gronchi, A, Haas, R L, Hassan, B, Hecker-Nolting, S, Hohenberger, P, Issels, R, Joensuu, H, Jones, R L, Judson, I, Jutte, P, Kaal, S, Kager, L, Kasper, B, Kopeckova, K, Krákorová, D A, Ladenstein, R, Le Cesne, A, Lugowska, I, Merimsky, O, Montemurro, M, Morland, B, Pantaleo, M A, Piana, R, Picci, P, Piperno-Neumann, S, Pousa, A L, Reichardt, P, Robinson, M H, Rutkowski, P, Safwat, A A, Schöffski, P, Sleijfer, S, Stacchiotti, S, Strauss, S J, Sundby Hall, K, Unk, M, Van Coevorden, F, van der Graaf, W T A, Whelan, J, Wardelmann, E, Zaikova, O, Blay, J Y, ESMO Guidelines Committee, PaedCan and ERN EURACAN

مصطلحات موضوعية: Adult, Aftercare, Age Factors, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Bone Neoplasms, Bone and Bones, Child, Europe, Humans, Incidence, Long-Term Care, Magnetic Resonance Imaging, Medical Oncology, Neoadjuvant Therapy, Neoplasm Staging, Orthopedic Procedures, Osteosarcoma, Patient Participation, Positron Emission Tomography Computed Tomography, Radionuclide Imaging, Radiotherapy, Adjuvant, Self-Help Groups, Societies, Medical, Survivorship, Treatment Outcome

العلاقة: http://hdl.handle.net/10668/13026Test; http://www.annalsofoncology.org/article/S0923753419317120/pdfTest

الإتاحة: https://doi.org/10.1093/annonc/mdy310Test
http://hdl.handle.net/10668/13026Test
http://www.annalsofoncology.org/article/S0923753419317120/pdfTest

المؤلفون: Casali, P.G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J.V.M.G., Brodowicz, T., Broto, J.M., Buonadonna, A., Alava, E., Tos, A.P., Muro, X.G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A.M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R.L., Hannu, A., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R.L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krakorova, D.A., Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M.A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A.L., Reichardt, P., Robinson, M.H., Rutkowski, P., Safwat, A.A., Schoffski, P., Sleijfer, S., Stacchiotti, S., Hall, K.S., Unk, M., Coevorden, F., Graaf, W.D., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J.Y., ESMO Guidelines Comm EURACAN

المساهمون: Casali, P.G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J.V.M.G., Brodowicz, T., Broto, J.M., Buonadonna, A., De Álava, E., Dei Tos, A.P., Del Muro, X.G., Dileo, P., Eriksson, M., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A.M., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R.L., Hannu, A., Hassan, B., Hohenberger, P., Issels, R., Joensuu, H., Jones, R.L., Judson, I., Jutte, P., Kaal, S., Kasper, B., Kopeckova, K., Krákorová, D.A., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Pantaleo, M.A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A.L., Reichardt, P., Robinson, M.H., Rutkowski, P., Safwat, A.A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Sundby Hall, K., Unk, M., Van Coevorden, F., Van Der Graaf, W., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J.Y., Man, Biomaterials and Microbes (MBM), Public Health Research (PHR), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Heikki Joensuu / Principal Investigator, Department of Oncology, Clinicum, HUS Comprehensive Cancer Center, [Casali, P. G.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy, [Frezza, A. M.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy, [Gronchi, A.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy, [Casali, P. G.] Univ Milan, Milan, Italy, [Frezza, A. M.] Univ Milan, Milan, Italy, [Gronchi, A.] Univ Milan, Milan, Italy, [Abecassis, N.] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Lisbon, Portugal, [Bauer, S.] Univ Hosp Essen, Essen, Germany, [Biagini, R.] Regina Elena Inst Canc Res, IFO, Musculoskeletal Tissue Bank, Dept Oncol Orthoped, Rome, Italy, [Bielack, S.] Olga Hosp, Klinikum Stuttgart, Stuttgart, Germany, [Bonvalot, S.] Inst Curie, Paris, France, [Piperno-Neumann, S.] Inst Curie, Paris, France, [Boukovinas, I.] NORDIX, Athens, Greece, [Bovee, J. V. M. G.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands, [Brodowicz, T.] Med Univ Wien, Vienna Gen Hosp AKH, Vienna, Austria, [Broto, J. M.] Hosp Univ Virgen Rocio, CIBERONC, Seville, Spain, [De Alava, E.] Hosp Univ Virgen Rocio, CIBERONC, Seville, Spain, [Buonadonna, A.] Ctr Riferimento Oncol Aviano, Aviano, Italy, [Dei Tos, A. P.] Osped Reg Treviso S Maria Ca Foncello, Treviso, Italy, [Del Muro, X. G.] HUB, ICO Hosp, Integrated Unit, Barcelona, Spain, [Dileo, P.] Univ Coll London Hosp, Sarcoma Unit, London, England, [Eriksson, M.] Skane Univ Hosp Lund, Lund, Sweden, [Fedenko, A.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia, [Ferraresi, V.] Inst Sci Hosp Care, Regina Elena Natl Canc Inst, IRCCS, Rome, Italy, [Ferrari, A.] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, Milan, Italy, [Ferrari, S.] Ist Ortoped Rizzoli, Bologna, Italy, [Picci, P.] Ist Ortoped Rizzoli, Bologna, Italy, [Gasperoni, S.] Univ Careggi Firenze, Azienda Osped, Florence, Italy, [Gelderblom, H.] Leiden Univ, Med Ctr, Dept Med Oncol, Leiden, Netherlands, [Gil, T.] Inst Jules Bordet, Brussels, Belgium, [Grignani, G.] IRCCS, FPO, Candiolo Canc Inst, Candiolo, Italy, [Haas, R. L.] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands, [Haas, R. L.] Leiden Univ, Med Ctr, Dept Radiotherapy, Leiden, Netherlands, [Hannu, A.] Turku Univ Hosp, Turun Yliopistollinen Keskussairaala, Turlu, Finland, [Hassan, B.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England, [Hohenberger, P.] Mannheim Univ, Med Ctr, Mannheim, Germany, [Kasper, B.] Mannheim Univ, Med Ctr, Mannheim, Germany, [Issels, R.] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, Munich, Germany, [Joensuu, H.] Univ Helsinki, Cent Hosp, HUCH, Helsinki, Finland, [Jones, R. L.] Royal Marsden Hosp, London, England, [Van der Graaf, W.] Royal Marsden Hosp, London, England, [Judson, I.] Inst Canc Res, London, England, [Jutte, P.] Univ Med Ctr Groningen, Groningen, Netherlands, [Kaal, S.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands, [Kopeckova, K.] Univ Hosp Motol, Prague, Czech Republic, [Krakorova, D. A.] Masaryk Mem Canc Inst, Brno, Czech Republic, [Le Cesne, A.] Gustave Roussy Canc Campus, Villejuif, France, [Lugowska, I.] Marie Sklodowska Curie Inst, Oncol Ctr, Warsaw, Poland, [Rutkowski, P.] Marie Sklodowska Curie Inst, Oncol Ctr, Warsaw, Poland, [Merimsky, O.] Tel Aviv Sourasky Med Ctr Ichilov, Tel Aviv, Israel, [Montemurro, M.] Univ Hosp Lausanne, Med Oncol, Lausanne, Switzerland, [Pantaleo, M. A.] Univ Bologna, Policlin S Orsola Malpighi, Azienda Osped, Bologna, Italy, [Piana, R.] Univ Cita Salute & Sci Torino, Azienda Osped, Turin, Italy, [Pousa, A. L.] Hosp Santa Creu & Sant Pau, Fundacio Gestio Sanitaria, Barcelona, Spain, [Reichardt, P.] Helios Klinikum Berlin Buch, Berlin, Germany, [Robinson, M. H.] Weston Pk Hosp NHS Trust, Dept Clin Oncol, YCRC, Sheffield, S Yorkshire, England, [Safwat, A. A.] Aarhus Univ Hosp, Aarhus, Denmark, [Schoffski, P.] Leuven Canc Inst, Leuven, Belgium, [Sleijfer, S.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands, [Stacchiotti, S.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Milan, Italy, [Hall, K. Sundby] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway, [Unk, M.] Inst Oncol Ljubljana, Ljubljana, Slovenia, [Van Coevorden, F.] Netherlands Canc Inst Antoni van Leeuwenhoek, Amsterdam, Netherlands, [Whelan, J.] Univ Coll Hosp, London, England, [Wardelmann, E.] Univ Klinikum Munster, Gerhard Domagk Inst Pathol, Munster, Germany, [Zaikova, O.] Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway, [Blay, J. Y.] Ctr Leon Bernard, Lyon, France, [Blay, J. Y.] UCBL1, Lyon, France, Amgen Dompe, AROG Bayer, Blueprint Medicines, Eli Lilly, Daiichi Sankyo Pharma, Epizyme, GlaxoSmithKline, Novartis, Pfizer, PharmaMar, Incyte, Lilly, Bayer, Janssen-Cilag, Eisai, Loxo Oncology, Nanobiotix, Bristol-Myers Squibb, Merck Sharp Dohme, Roche, Amgen, EuroSarc, CoBioRes, Exelixis, Plexxikon, Sixth Element Capital, Adaptaimmune, Amcure, AstraZeneca, Boehringer Ingelheim, Cristal Therapeutics, Daichii Sankyo Pharma, Genzyme, Ipsen, Medpace, Nektar, Philogen, Piqur Therapeutics, Swedish Orphan Biovitrium, Advenchen, Epizyme Inc., PharmarMar, Novartis Oncology, Milestone, Menarini, Medical Oncology

المصدر: Annals of Oncology, 29, iv68-iv78
Annals of Oncology, 29, Supplement_4, pp. iv68-iv78
Annals of Oncology, 29, 68-78
ANNALS OF ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Annals of Oncology, 29, 68-78. Oxford University Press
Annals of Oncology, 29, 68-78. Elsevier Ltd.

مصطلحات موضوعية: SURGERY, medicine.medical_treatment, Medizin, Aftercare, Medical Oncology, law.invention, DOSE IMATINIB, Endosonography, 0302 clinical medicine, Randomized controlled trial, law, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Medicine, Digestive System Surgical Procedures, Societies, Medical, Adjuvant imatinib, NEOADJUVANT/ADJUVANT IMATINIB MESYLATE, GiST, Progression, Incidence, Stomach, Margins of Excision, KIT, Hematology, Gastrointestinal stromal tumours, 3. Good health, Clinical Practice, Europe, Intestines, Self-Help Groups, Treatment Outcome, Diagnosis treatment, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology, ADJUVANT IMATINIB, Neoadjuvant/adjuvant imatinib mesylate, PHASE-II TRIAL, Mutations, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], GIST, Adult, Image-Guided Biopsy, medicine.medical_specialty, Gastrointestinal Stromal Tumors, education, 3122 Cancers, 03 medical and health sciences, Stomach surgery, Carney-stratakis, CARNEY-STRATAKIS, Humans, Gist, Neoplasm Staging, Chemotherapy, business.industry, MUTATIONS, General surgery, ta3121, RANDOMIZED-TRIAL, digestive system diseases, Imatinib mesylate, Phase-ii trial, 3121 General medicine, internal medicine and other clinical medicine, Surgery, Laparoscopy, Patient Participation, business, Dose imatinib, Tomography, X-Ray Computed

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9705c9164199c5339b8a4b2dd980f8aTest
https://ora.ox.ac.uk/objects/uuid:17842f8f-8914-49d9-8c8f-c91fc9a08743Test

المؤلفون: Woll, P, Reichardt, P, Le Cesne, A, Bonvalot, S, Azzarelli, A, Hoekstra, H, Leahy, Michael G, Van Coevorden, F, Verweij, J, Hogendoorn, P, Ouali, M, Marreaud, S, Bramwell, Vivien H C, Hohenberger, P

المساهمون: University of Sheffield, Sheffield, UK.

مصطلحات موضوعية: Adolescent, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Doxorubicin, Female, Granulocyte Colony-Stimulating Factor, Humans, Ifosfamide, Male, Middle Aged, Recombinant Proteins, Sarcoma

العلاقة: Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. 2012, 13 (10):1045-54 Lancet Oncol; http://hdl.handle.net/10541/263678Test; The Lancet Oncology

الإتاحة: https://doi.org/10.1016/S1470-2045Test(12)70346-7
http://hdl.handle.net/10541/263678Test

المؤلفون: Woll, P.J., Reichardt, P., Cesne, A. le, Bonvalot, S., Azzarelli, A., Hoekstra, H.J., Leahy, M., Coevorden, F. van, Verweij, J., Hogendoorn, P.C.W., Ouali, M., Marreaud, S., Bramwell, V.H.C., Hohenberger, P., EORTC Soft Tissue Bone Sarcoma Grp, NCIC Clinical Trials Grp Sarcoma D

المساهمون: Medical Oncology, Faculteit Medische Wetenschappen/UMCG

المصدر: Lancet Oncology, 13(10), 1045-1054. Lancet Publishing Group
Lancet Oncology, 13(10), 1045-1054. ELSEVIER SCIENCE INC

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Adolescent, medicine.medical_treatment, EUROPEAN-ORGANIZATION, EXTREMITIES, PLUS IFOSFAMIDE, Lenograstim, NEOADJUVANT CHEMOTHERAPY, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, medicine, Humans, Doxorubicin, Ifosfamide, METAANALYSIS, Aged, Chemotherapy, Performance status, business.industry, Soft tissue sarcoma, Sarcoma, ADULTS, Middle Aged, COLONY-STIMULATING FACTOR, medicine.disease, Recombinant Proteins, Surgery, Radiation therapy, Oncology, Chemotherapy, Adjuvant, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3ea0b5dfdb070d809970ed76c87bad8Test
https://hdl.handle.net/1887/99062Test

المؤلفون: Laurence Brugières, K. Sundby Hall, Bruce Morland, Ioannis Boukovinas, Rolf D. Issels, Sebastian Bauer, D.A. Krakorova, Angela Buonadonna, E. de Álava, Nathalie Gaspar, P. Picci, Palma Dileo, Hans Gelderblom, Bernadette Brennan, Javier Martin Broto, Maria Abbondanza Pantaleo, Paul C Jutte, Ian Judson, Suzanne E. J. Kaal, B. Hassan, Ruth Ladenstein, Alexander Fedenko, Patrick Schöffski, Jean-Yves Blay, A. Le Cesne, Peter Hohenberger, Virginia Ferraresi, Sandra J. Strauss, Michael Montemurro, Robin L. Jones, Peter Reichardt, Stefan S. Bielack, Mikael Eriksson, Stefan Sleijfer, Akmal Safwat, Heikki Joensuu, Rick L. Haas, Bernd Kasper, Hannu T. Aro, Judith V.M.G. Bovée, Jeremy Whelan, A.M. Frezza, Antonio López Pousa, Stefanie Hecker-Nolting, Thomas Brodowicz, R. Biagini, Silvia Stacchiotti, S. Ferrari, Sylvie Bonvalot, S. Piperno-Neumann, Leo Kager, F. van Coevorden, Olga Zaikova, R. Piana, Catharina Dhooge, Piotr Rutkowski, M.H. Robinson, Ofer Merimsky, Katerina Kopeckova, X.G. del Muro, W.T.A. van der Graaf, Paolo G. Casali, N. Abecassis, Eva Wardelmann, Silvia Gasperoni, Giovanni Grignani, A. P. Dei Tos, Andrea Ferrari, Franca Fagioli, Alessandro Gronchi, Thierry Gil, Iwona Lugowska, M. Unk

المساهمون: Man, Biomaterials and Microbes (MBM), Public Health Research (PHR), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Medical Oncology, Casali, P.G., Bielack, S., Abecassis, N., Aro, H.T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J.V.M.G., Brennan, B., Brodowicz, T., Broto, J.M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A.P., Del Muro, X.G., Dileo, P., Dhooge, C., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A.M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R.L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R.L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D.A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Morland, B., Pantaleo, M.A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A.L., Reichardt, P., Robinson, M.H., Rutkowski, P., Safwat, A.A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Strauss, S.J., Sundby Hall, K., Unk, M., Van Coevorden, F., Van Der Graaf, W.T.A., Whelan, J., Wardelmann, E., Zaikova, O., Blay, J.Y.

المصدر: Annals of Oncology, 29, iv79-iv95
Annals of Oncology, 29, 79-95. Oxford University Press
Annals of Oncology, 29, 79-95
Annals of Oncology, 29, Supplement_4, pp. iv79-iv95
Annals of Oncology, 29, 79-95. Elsevier Ltd.
ESMO Guidelines Committee, PaedCan and ERN EURACAN 2018, ' Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up ', Annals of Oncology, vol. 29, no. Supplement_4, pp. 79-95 . https://doi.org/10.1093/annonc/mdy310Test
ANNALS OF ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Digital.CSIC. Repositorio Institucional del CSIC

مصطلحات موضوعية: 0301 basic medicine, Oncology, Biopsy, Medizin, Aftercare, CHILDRENS-ONCOLOGY-GROUP, Survivorship, Medical Oncology, 0302 clinical medicine, HIGH-DOSE CHEMOTHERAPY, Positron Emission Tomography Computed Tomography, Antineoplastic Combined Chemotherapy Protocols, GIANT-CELL TUMOR, Orthopedic Procedures, PRIMITIVE NEUROECTODERMAL TUMOR, Child, Societies, Medical, Osteosarcoma, SOFT-TISSUE TUMORS, Incidence (epidemiology), Incidence, Age Factors, Hematology, RANDOMIZED CONTROLLED-TRIAL, Magnetic Resonance Imaging, Neoadjuvant Therapy, Europe, Self-Help Groups, Treatment Outcome, 030220 oncology & carcinogenesis, Sarcoma, HIGH-GRADE OSTEOSARCOMA, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, medicine.medical_specialty, education, Bone Neoplasms, Bone Sarcoma, Bone and Bones, 03 medical and health sciences, POSITRON-EMISSION-TOMOGRAPHY, Internal medicine, medicine, Humans, Radionuclide Imaging, STUDY-GROUP PROTOCOLS, Neoplasm Staging, ta3126, NONMETASTATIC EWINGS-SARCOMA, business.industry, Cancer, medicine.disease, Long-Term Care, Cancer registry, 030104 developmental biology, Primitive neuroectodermal tumor, Radiotherapy, Adjuvant, Chondrosarcoma, Patient Participation, business

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a742df37d742c9c8b5f3510fae81283Test
https://hdl.handle.net/1887/96049Test